Browse studies, page 122
Page 122 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- A Review on the Role of Moxifloxacin in the Treatment and Management of Respiratory Tract Infections Journal of Pharma Insights and Research, 2025
- Large-Scale Analysis of Age and Sex Effects on Corrected QT and JT Intervals: Insights From Hospital-Based Controls and Moxifloxacin-Treated Cases Clinical and Translational Science, 2025
- Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1 Antibiotics, 2025
- Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial EClinicalMedicine, 2025
- Metal chelation approach synergized with surfactant for spectrofluorimetric assay of moxifloxacin with method greenness evaluation BMC Chemistry, 2025
- Efficacy of topical moxifloxacin on therapeutic laparoscopy-induced wound healing: a double-blind, randomized clinical trial BMC Surgery, 2025
- Combined cellulose acetate butyrate and palmitic acid solvent exchange-driven phase inversion in situ gel loading moxifloxacin HCl for periodontitis therapy International Journal of Biological Macromolecules, 2025
- Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations IJTLD open, 2025
- Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats Frontiers in Pharmacology, 2025
- Amide-functionalized cellulose derived from sugarcane bagasse for efficient removal of amoxicillin and moxifloxacin from water International Journal of Biological Macromolecules, 2025
- Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis British Journal of Clinical Pharmacology, 2025
- Host Biomarkers and Antibiotic Tissue Penetration in Sepsis: Insights from Moxifloxacin European journal of drug metabolism and pharmacokinetics, 2025
- Selective six spectrophotometric methods for determination of remdesivir and moxifloxacin hydrochloride for COVID-19 treatment with overlapping spectra: a comprehensive evaluation of greenness, blueness, and whiteness BMC Chemistry, 2025
- Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment Scientific Reports, 2025
- Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB. Journal of Antimicrobial Chemotherapy, 2025
- Moxifloxacin‐Impregnated Contact Lenses for Treatment of Keratitis in Rabbit Eyes Polymers for Advanced Technologies, 2025
- Investigation of ternary Zn–Co–Fe layered double hydroxide as a multifunctional 2D layered adsorbent for moxifloxacin and antifungal disinfection Scientific Reports, 2024
- Development and optimization of Moxifloxacin solid lipid nanoparticles via double emulsion organic solvent free technique applying Box–Behnken experimental design Scientific Reports, 2025
- Multifunctional moxifloxacin and essential oil loaded sodium alginate/thiolated karaya gum hydrogel dressings for improved wound healing International Journal of Biological Macromolecules, 2025
- Moxifloxacin in HPMC-nanocellulose composite film for the management of ocular inflammation: Effect of carboxymethylated gum on permeation and antimicrobial activity International Journal of Biological Macromolecules, 2025
- Challenges to initiate and complete a 4-month rifapentine-moxifloxacin TB treatment regimen The International Journal of Tuberculosis and Lung Disease, 2025
- Development of sustained-release extemporaneous moxifloxacin loaded commercial soft hydrogel contact lenses Heliyon, 2025
- An Ultra-Sensitive Colorimetric Sensing Platform for Simultaneous Detection of Moxifloxacin/Ciprofloxacin and Cr(III) Ions Based on Ammonium Thioglycolate Functionalized Gold Nanoparticles Italian National Conference on Sensors, 2025
- Novel anionic functionalized magnetic β-cyclodextrin composites with excellent adsorption capacity for moxifloxacin and wide pH adaptive adsorption capability for copper ion Environmental Research, 2025
- Moxifloxacin-Loaded Polymeric Nanoparticles for Overcoming Multidrug Resistance in Chronic Pulmonary Infections Caused by Pseudomonas aeruginosa ACS Applied Materials and Interfaces, 2025
- Moxifloxacin-loaded PVA-chitosan composite films as potential ocular drug delivery systems: A comprehensive characterization and efficacy assessment International Journal of Biological Macromolecules, 2025
- Dual emission ratiometric fluorescence probe based on N-doped carbon dots and coumarin derivatives for determination of moxifloxacin and copper ion Analytica Chimica Acta, 2025
- Outcomes of Staphylococcus aureus Keratitis: A Retrospective Comparison of Methicillin-Resistant and Methicillin-Susceptible Isolates Cornea, 2026
- Favorable Outcome With Early Vitrectomy for Pseudomonas Endophthalmitis Following Elective Pars Plana Vitrectomy for Disabling Vitreous Opacities Case reports in ophthalmological medicine, 2026
- Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments Journal of controlled release : official journal of the Controlled Release Society, 2026
- Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform Antimicrobial agents and chemotherapy, 2024
- Insights into antibiotic resistance promoted by quinolone exposure Antimicrobial agents and chemotherapy, 2025
- Rare case report of moxifloxacin-induced persistent hiccups European journal of hospital pharmacy : science and practice, 2024
- Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: A novel dropless regimen Indian journal of ophthalmology, 2024
- Moxifloxacin-loaded nanoparticles of thiolated xyloglucan for ocular drug delivery: Permeation, mucoadhesion and pharmacokinetic evaluation International journal of biological macromolecules, 2024
- In vitro evolution provides insights into mechanisms of Mycoplasma genitalium resistance to moxifloxacin The Journal of antimicrobial chemotherapy, 2025
- Population pharmacokinetics and dose evaluation for second-line TB drugs in patients with diabetes The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025
- Impact of Airborne Exposure to PM10 Increases Susceptibility to P. aeruginosa Infection International journal of environmental research and public health, 2024
- Evaluation of Rusfertide, a Hepcidin Mimetic, on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT Study in Healthy Participants Clinical therapeutics, 2025
- A hollow fiber infection model to study intracellular and extracellular antibiotic activity against Staphylococcus aureus iScience, 2025
- EFP Analyzer: A fast, accurate, and easy-to-teach program for analyzing Extracellular Field Potentials from iPSC-derived cardiomyocytes bioRxiv : the preprint server for biology, 2024
- Drug resistance patterns and treatment outcomes in DR-TB patients at a tertiary care centre in Mumbai The Indian journal of tuberculosis, 2024
- Ocular bioanalysis of moxifloxacin and ketorolac tromethamine in rabbit lacrimal matrix using liquid chromatography-tandem mass spectrometry Bioanalysis, 2024
- Therapeutic efficacy of moxifloxacin and marbofloxacin against mastitis in buffalo Tropical animal health and production, 2025
- Rifapentine dosing for drug-susceptible tuberculosis: stage 1 of a seamless phase 2/3 randomized clinical trial Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026
- Moxifloxacin-Induced Seizures: A Case Report Cureus, 2025
- Intracameral antibiotics during cataract surgery: efficacy, safety, and cost-benefit considerations Current opinion in ophthalmology, 2024
- A New Ray of Hope in the Treatment of Seasonal Hyperacute Panuveitis: Could Intravitreal Triple Combination Therapy of an Antibiotic with Dual Steroids Play a Pivotal Role? Ocular immunology and inflammation, 2025
- Acute and chronic responses of nitrifying culture under moxifloxacin exposure Environmental technology, 2026
- Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source JAC-antimicrobial resistance, 2024
- Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial The Lancet. Infectious diseases, 2025
- Delayed Repolarization Caused by hERG Block With Different Drug Modalities Can Be Detected in Stem Cell-Derived Cardiomyocytes: Incubation Time Matters Clinical and translational science, 2025
- Dual antibiotic PLGA microspheres for the treatment of traumatic osteomyelitis Scientific reports, 2025
- Clinical Characteristics of Moxifloxacin-Related Arrhythmias and Development of a Predictive Nomogram: A Case Control Study Journal of clinical pharmacology, 2024
- A randomized phase 1 study investigating gut microbiome changes with moxifloxacin vs. oral vancomycin: Implications for Clostridioides difficile risk The Journal of infectious diseases, 2025
- Design, Synthesis, and Bioevaluation of Moxifloxacin Hydrazide Metal Complexes: Integrated Spectroscopic, Computational, Antimicrobial, and Anticancer Investigations International journal of molecular sciences, 2026
- Applying a Pharmacometrics-Enabled Machine Learning Analysis to Predict 2-Month Culture Conversion Using Phase 2a Data in a Tuberculosis Clinical Trial Clinical and translational science, 2026
- Synergistic moxifloxacin detection: AgNPs/GO electrochemical immunosensor with oriented antibody immobilization Food chemistry, 2025
- Retrospective analysis on the outcomes of contact lens-associated keratitis in a tertiary centre: an evidence-based management protocol to optimise resource allocation The British journal of ophthalmology, 2024
- Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan Journal of cardiovascular pharmacology and therapeutics, 2025
- No Influence of Asundexian on Cardiac Repolarization Clinical pharmacology in drug development, 2024
- Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection Journal of controlled release : official journal of the Controlled Release Society, 2025
- In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium The Journal of antimicrobial chemotherapy, 2025
- Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial The Lancet. Infectious diseases, 2025
- Efficacy of intracameral moxifloxacin in prevention of postcataract surgery endophthalmitis: randomized control trial Journal of cataract and refractive surgery, 2026
- Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025
- Pharmacokinetic and pharmacodynamic evaluations of oral moxifloxacin for Enterococcus faecalis endocarditis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026
- Microbiological Profile of Post-cataract Surgery Endophthalmitis with Usage of Prophylactic Intracameral Moxifloxacin Ocular immunology and inflammation, 2024
- A Kounis syndrome following moxifloxacin and deflazacort administration European journal of case reports in internal medicine, 2024
- Advances in antibiotic therapy for tuberculosis La Revue du praticien, 2024
- Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections Current therapeutic research, clinical and experimental, 2024
- An overview of Buruli ulcer in Australia Australian journal of general practice, 2024
- No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment Pharmacology research & perspectives, 2025
- Bilateral choroidal tuberculoma in a patient of miliary tuberculosis Journal of ophthalmic inflammation and infection, 2025
- Recent advancements in tuberculosis (TB) treatment regimens Journal of family medicine and primary care, 2025
- A clinical metagenomic study of biopsies from Mexican endophthalmitis patients reveals the presence of complex bacterial communities and a diversity of resistance genes Access microbiology, 2024
- Moxifloxacin HCl -loaded Cellulose Acetate Butylate In Situ Forming Gel for Periodontitis Treatment AAPS PharmSciTech, 2024
- Can febrile neutropenia re-invent its self? Current opinion in oncology, 2025
- Eco-friendly moxifloxacin removal using date seed waste and Ni-Fe LDH: Adsorption efficiency and antimicrobial potential Ecotoxicology and environmental safety, 2025
- Understanding the impact of moxifloxacin on immune function: Findings from cytokine analyses and immunological assays in mice PloS one, 2025
- Efficacy of regimens targeting Mycobacterium abscessus in vitro and in vivo BMC microbiology, 2026
- Mycoplasma genitalium: Key Information for the Primary Care Clinician The Medical clinics of North America, 2024
- Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis Journal of clinical tuberculosis and other mycobacterial diseases, 2024
- A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants Clinical pharmacology in drug development, 2026
- Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus Antimicrobial agents and chemotherapy, 2024
- Overcoming Antimicrobial Resistance in Bacterial Keratitis With an Antibiotic-Eluting Contact Lens Investigative ophthalmology & visual science, 2025
- Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections Journal of controlled release : official journal of the Controlled Release Society, 2025
- Effect of a Supratherapeutic Dose of Omaveloxolone on the Corrected QT Interval in Healthy Participants: A Randomized, Double-Blind, Placebo- and Active-Controlled, Three-Way Crossover Study Clinical and translational science, 2025
- The mutant selection window of moxifloxacin and bedaquiline resistant Mycobacterium tuberculosis The Journal of infection, 2025
- Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TB. The Indian journal of medical research, 2025
- Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020 Emerging infectious diseases, 2025
- A modelling framework to characterize the impact of antibiotics on the gut microbiota diversity Gut microbes, 2025
- A Mycobacteria-Specific Prodrug to Overcome Phenotypic AMR in Mycobacterium tuberculosis Journal of medicinal chemistry, 2025
- Engineering Moxifloxacin-Encapsulated Liposome-Enriched Alginate Hydrogel Films Gels (Basel, Switzerland), 2025
- BPaLM Regimen Against Drug-Resistant Tuberculosis in India: A Need of the Hour Cureus, 2024
- Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants Clinical and translational science, 2025
- Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial The Lancet. Infectious diseases, 2024
- Pharmacovigilance of five commonly used antibiotics in acute exacerbations of COPD (AECOPD): Analysis of the FDA adverse event reporting system database Pulmonary pharmacology & therapeutics, 2025
- Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial The Lancet. Respiratory medicine, 2024
- Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial JAMA ophthalmology, 2025
